Abstract
In a double-blind, randomised trial, neither aprotinin nor glucagon given in relatively high doses for five days influenced the rate of recovery or incidence of complications in 257 patients with acute pancreatitis.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Condon J. R., Knight M., Day J. L. Glucagon therapy in acute pancreatitis. Br J Surg. 1973 Jul;60(7):509–511. doi: 10.1002/bjs.1800600703. [DOI] [PubMed] [Google Scholar]
- Gilsanz V., Oteyza C. P., Rebollar J. L. Glucagon vs anticholinergics in the treatment of acute pancreatitis. A double-blind controlled trial. Arch Intern Med. 1978 Apr;138(4):535–538. [PubMed] [Google Scholar]
- Imrie C. W., Benjamin I. S., Ferguson J. C., McKay A. J., Mackenzie I., O'Neill J., Blumgart L. H. A single-centre double-blind trial of Trasylol therapy in primary acute pancreatitis. Br J Surg. 1978 May;65(5):337–341. doi: 10.1002/bjs.1800650514. [DOI] [PubMed] [Google Scholar]
- Waterworth T. A., Bevan P. G. Proceedings: Effect of glucagon on pain in acute pancreatitis. Ann R Coll Surg Engl. 1976 Jul;58(4):323–323. [PMC free article] [PubMed] [Google Scholar]